Tgth-0100

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameTgth-0100
Drug Alias NamePdx -1
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionRegenerating islet-derived protein 3-alpha agonists
TargetsRegenerating islet-derived protein 3-alpha
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTransgeneron Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTransgeneron Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A